• picture

What is NEO-CIRC?

Neo-Circ Consortium

NEO-CIRC:

- will focus on the use of the drug dobutamine for the treatment of circulatory failure in the first two days after birth

- sustained low blood pressure and impaired blood flow to organs, during this period, can cause brain injury resulting in poor neurodevelopmental outcomes

- neurodevelopmental disorders are associated with mental, emotional and physical disorders of varying severity

- there is strong evidence that the use of dobutamine will reduce the incidence of these disabilities

read more >>

Latest news

NEOCIRC 003 TRIAL: Additional study centres required
We are now recruiting additional study centres to conduct a large randomised study in infants < 33 weeks gestation.

NeoCirc-001A completed!
The 1st phase of NEOCIRC001 trial is complete after recruiting the required number of babies.

NEOCIRC participates at the First Annual Neonatal Scientific Workshop in USA
M Turner and H Rabe were an invited Panel members and Speakers at the First Annual Neonatal Scientific Workshop.

View all news >>

Events

5th NEO-CIRC Consortium Budapest - January 2016

On the 25th and 26th of January 2016, the Neocirculation Consortium held its Consortium Meeting in Budapest chaired by Heike Rabe the Project Coordinator

4th NEO-CIRC Consortium Meeting

The 4th NEO-CIRC Consortium Meeting to take place in the city of Cluj-Napoca in Romania.

NEO-CIRC Consortium Meeting Scheduled

The next NEO-CIRC Consortium Meeting will be held in Lübeck, Germany on the 19th – 20th March 2013.

View all events >>